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Complex role of protein phosphorylation in gene activation by
hypoxia. Mammalian cells are able to sense decreased oxygen
tension in their environment and turn-on the expression of
specific hypoxia responsive genes. The best studied of these
hypoxia regulated genes is the one that encodes for erythropoie-
tin, the glycoproteiri hormone that regulates red cell production
[1]. The response of the erythropoietin gene to hypoxia is
mediated by an enhancer sequence located at the 3' flanking
region of the gene [2—4]. A hypoxia inducible DNA-binding
protein complex, termed HIF-1, regulates the transcriptional
function of the erythropoietin enhancer [5]. Most interestingly,
identical HIF-1 complexes also control the responses of other
hypoxia regulated genes, in what appears to be a general mecha-
nism of oxygen sensing and response [6, 7]. These other hypoxia
regulated genes include vascular endothelial growth factor, glyco-
lytic enzymes such as pyruvate kinase and aldolase A, glucose
transporter I and endothelin, among others. All these genes are
transcriptionally activated by hypoxia and also by transition metals
such as cobalt (Co) and by iron chelators such as desferrioxamine
(Dfx) [reviewed in 8].
Recently Wang and Semenza purified the protein components
of the HIF-1 DNA-binding complex [9, 10]. Their biochemical
purification revealed the presence of one subunit of about 120
kDa (HIF-la) and a second subunit, HIF-1f3 with polypeptides of
91, 93 and 94 kDa with a similar tryptic digestion composition.
Cloning of the corresponding cDNAs showed that both subunits
belong to a subfamily of basic-helix-loop-helix (b-HLH) transcrip-
tion factors containing a PAS domain. HIF-Ia resulted to be a
newly recognized member of the group while HIF-1/3 turn out to
be the already described aryl hydrocarbon receptor nuclear
translocator (ARNT) protein. These two proteins appear to form
a heterodimer complex which then interact with the putative
hypoxia-enhancer sequences. The mechanisms involved in the
hypoxic induction of this DNA-binding complex are still not clear.
Regulation of HIF-1 complex formation
ARNT is also the partner of the aryl hydrocarbon receptor
(AhR) where in the heterodimeric complex regulates the xenobi-
otic response of several genes including those of the cytochrome
P450 family [11]. The absolute requirement of ARNT in the
hypoxia response was recently demonstrated in ARNT deficient
cells [12, 131. These cells neither induced HIF-1 binding activity in
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response to hypoxia nor expressed hypoxia responsive genes. The
studies in ARNT deficient cells also showed that HIF-la and 13
mRNAs levels did not change under hypoxic conditions, indicat-
ing that HIF-1 complex formation was not regulated at the mRNA
level of its protein components. The unresponsiveness of HIF-1 a
and /3 mRNA to hypoxia was confirmed in Hep3B cells. As shown
by the Northern blot in Figure 1, exposure of Hep3B cells to
hypoxia (Hx), cobalt (Co) or desferrioxamine (Dfx) from two to
sixteen hours show no change in either ARNT or HIF-la
mRNAs, whereas the mRNA for erythropoietin accumulates in
time. These results clearly indicate that HIF-la protein is regu-
lated either at the level of its translation or by modifications of its
rate of degradation. Since ARNT protein is constitutively ex-
pressed, HIF-1 complex DNA-binding activity is likely controlled
by the availability of the HIF-la subunit.
Protein phosphorylation and signal transduction
The mechanisms of oxygen sensing and signal transduction in
the hypoxia response are still unknown. Protein phosphorylation
is a widely used mechanism of signal transduction that has also
been implicated in gene activation by low oxygen tension [14—16].
To study the role of phosphorylation in the response to hypoxia
we utilized several protein kinase inhibitors of different specificity.
These studies were initially conducted in B-I cells, a permanently
transfected Hep3B derived cell line expressing a Luciferase
reporter eDNA under the control of a minimal erythropoietin
promoter and the hypoxia responsive enhancer. These cells give a
very sensitive and reproducible Luciferase response to hypoxia,
cobalt and desferrioxamine. Results with the use of H-7, a rather
general protein kiriase inhibitor, showed an almost complete
inhibition of the Luciferase response to all three stimuli as
depicted in Figure 2A. These initial results confirmed the role of
protein phosphorylation in the hypoxia response. No effect on
Luciferase expression was observed with the use of Wortmannin,
a P1-3 kinase inhibitor (not shown), whereas Calphostin C, a
protein kinase C inhibitor, was a strong inhibitor against Co and
Dfx, but showed poor activity against hypoxia (Fig. 2B). Genistein,
a protein tyrosine kinase inhibitor was also a potent inhibitor
against all three stimuli as shown in Figure 3A. The inhibition
observed by these compounds on Luciferase activity was further
evaluated by Northern blot analysis of the endogenous erythro-
poietin gene (Fig. 3B), which confirmed the absolute inhibitory
effect of Genistein (G) and the partial effect of Calphostin C (C).
Also shown in this Figure is the lack of effect of these inhibitors on
the expression of HJF-1 a or /3 mRNAs.
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Fig. 1. Time course effect of hypoxia (Hx), desferrioxamine (Df) and cobalt
(Ca) on gene expression in Hep3B cells. Cells were exposed to the different
agent from 2 to 16 hours and RNA was analyzed by Northern blot utilizing
probes to human erythropoietin (Epo), HIF-la, ARNT and actin.
The marked inhibitory effect of Genistein, as also reported
originally by Wang et al [161, prompted us to use PD 098059, a
selective MEK inhibitor [17]. MEK1 and MEK2 are dual-speci-
ficity MAP kinases that phosphorylate the two isoforms of ERK
(p42 and p44), the terminal kinases of the mitogen activated
protein kinase (MAP) module. Although this signal transduction
pathway has been traditionally associated with mitogenic re-
sponses, there is also recent evidence for its involvement in stress
mediated responses [18]. As shown in Figure 4A, PD 098059
produced a dose dependent inhibition of the Luciferase response
to Hx, Co and Dfx, with about 70% inhibition at 50 xM. To further
study the mechanism of action of PD 098059, we evaluated its
effects on HIF-1 complex formation. Nuclear extracts obtained
from normal, 1-Ix, Co and Dfx treated cells were analyzed using gel
shift assays with a radiolabeled HIF-1 binding site. Surprisingly, as
shown in Figure 4B, PD 098059 had no effect on HIF-1 DNA
binding activity induced by either stimulus. These results suggest
first that there could be dissociation between DNA-binding
activity and transcriptional activation, and second, it indicates that
protein phosphorylation is likely involved in the trans-activating
function of the HIF-1 complex. This lack of effect of protein
phosphorylation on DNA-binding activity was further confirmed
by the treatment of nuclear extracts with protein phosphatases,
which showed no effect on DNA-binding activity (not shown). A
similar dissociation between DNA-binding and transcriptional
activation was recently described for the stress-induced phosphor-
ylation and activation of the transcription factor CHOP, a mem-
ber of the C/EBP family [191.
Although significant advances have been made recently in our
understanding of the mechanisms that regulate the responses to
hypoxia, major questions still remain unanswered. Within these
unknowns are the signal transduction pathways that determine the
formation of the HIF-1 complex and the mechanisms used by this
complex to increase transcriptional activity. Protein phosphoiyla-
tion is a common mechanism utilized by the cell for the rapid
transmission of extracellular signals to their intracellular targets.
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Fig. 2. Effect of protein kinase inhibitors on Luciferase activity in B-i cells.
A. Cells were exposed to hypoxia (LI Fix), cobalt (+ Co) or desferriox-
amine (K Dfx) for eight hours in the presence of increasing concentra-
tions of H-7. Symbol • is normal. B. Cells were exposed, as above, to
increasing concentrations of Calphostin C.
The transmission of these signal is usually mediated by a network
of interacting protein kinases that governs a large number of
cellular processes, including the transcriptional activation of
genes. The studies presented here clearly confirm early reports of
the involvement of protein phosphorylation events in the signal
transduction of the hypoxia response. The pattern of phosphory-
lation is, however, rather complex. Inhibitors of protein kinase C
were very effective in blocking the response to cobalt and desfer-
rioxamine, but had little effect in the response to hypoxia. The
tyrosine phosphorylation inhibitor Genistein was very effective
against all stimuli and blocked both HIF-1 binding activity and
gene expression. On the other hand, PD 098059, a highly specific
inhibitor of the MAP pathway, inhibited gene expression, but not
HIF-1 DNA-binding (Note added in proof). The results presented
have just outlined the complexities of the signal tranduction
pathways that culminate in gene activation in response to hypoxia.
Hep3B cells
ARNT
EPO
H IF-la
Actin
A
80000
70000
60000
50000
40000
30000
CE 20000 -
10000
0
N
----
--------
I I
0 5 10 15 20 25 30 35 40
H-7, l.tM
B
a a a fl
t•-4
;SSE at
558 Salceda et a!: Gene activation by hypoxia
HIF-ict—
ARNT—
B
N Hx Dfx Co
I II II II
-GC- G C-G C NGC
Fig. 3. A. Effect of Genistein on Luciferase expression by B-I cells. Cells
were exposed, as in Figure 2, to Genistein for eight hours. Symbols are:
(U) normal; (LII) hypoxia; (•) desferrioxamine; () cobalt. B. Northern
blot analysis of total RNA obtained from normal (N) or stimulated B-i
cells in the presence of 100 /.LM Genistein (G) or 100 nM Calphostin C (C).
More studies will be needed to determine the mechanism by
which low oxygen tension initiates these events, the nature of the
protein kinases involved and the exact role of phosphorylation in
the transactivation activity of the HIF-l complex.
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Note added in proof
Although PD 09859 has been described as a specific inhibitor of MEK
[171, preliminary results from our laboratory suggest that it could also
affect the activity of P450 enzymes. The possible confounding effects of
this finding on our results are currently being investigated.
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Fig. 4. Effect of PD 098059 on the response to Hx, Co and Dfx by B-i cells.
A. Cells were exposed for 6 hours to the different agents, as above, in the
presence of increasing concentrations of PD 098059. Symbols are: (U) N;
(LI) Hx; (•) Dfx; () Co. B. Gel shift assay utilizing nuclear extracts from
normal and treated cells, as above, in the absence (—) or presence (+) of
50 ILM of PD098059. Labeled probe from the Epo 3' enhancer.
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